However, the result of applying the PRISMA criteria is that this based on just nine studies with diverse study designs, covering 239 patients given ketamine in very different treatment regimes compared to 249 controls. Therefore, when the authors attempt to disaggregate the main finding by IA versus IV and by early and late post-operative period, they are often comparing one or two very different studies, each comprising only 20 or 30 patients given ketamine (see Table1). It is unclear whether effect sizes based on one or two studies are controlled for other confounding factors that distinguish the studies, as some of the corrections required could not have been undertaken by the authors of the original studies.
For these reasons, the authors should be more cautious in presenting their disaggregated findings, particularly in the abstract.
Specifically, it would be more informative if the authors (i) in the abstract, presented the number of studies on which a disaggregated finding is based (ii) in both the abstract and results, indicated the pooled sample sizes (cases and controls) on which disaggregated results are based (iii) in the results section, when presenting disaggregated results based on only one or two studies, indicate the confounding factors in the study design that might have contributed to the finding and whether or not that was addressed by the original author of the paper.
Specific drafting points
Page 2, lines 44 to 48 (overall conclusion) The IA results quoted seem to be based on just one paper with 21 patients -requires some qualification.
Page 9, line 236 to 239 The words "regards to" are missing from "with the gastrointestinal" and "with the psychotic" Page 10 line 248 to 250 Since there was only one small study of epidural administration and one slightly larger study of IA, should these be excluded from the main findings of the paper and the results presented in terms of the efficacy and safety of IV administration (based on 202 patients given ketamine)?
REVIEWER
Vesa Kontinen Helsinki University Hospital Finland Author of the Brinck et al 2019 Cochrane review on periperative intravenous ketamine for postoperative pain. REVIEW RETURNED 14-Apr-2019
GENERAL COMMENTS
This is a systematic review on the effects of perioperative ketamine on postoperative pain after total hip or knee arthroplasty. Intravenous, intraarticular and epidural administration routes were studied.
Most of the trials where intravenous ketamine has been studied are included in the resent large Cochrane review on this topic (Brinck et al 2018), and analysed there as a separate subgroup of orthopaedic studies. There also several other systematic reviews on perioperative ketamine for postoperative pain after different types of surgery. Thus, this review does not add substantially to the knowledge on this topic.
On a mechanistic view, the site of action and the pharmacological mechanism of intra-articular ketamine is especially problematic after total arthroplasty, when the possible targets within the joint have been removed and replaced with the prosthesis. It would be helpful to discuss what could be the mechanism of action and target site of the intra-articular ketamine after total arthroplasty. Does the joint act merely as a depot for delayed systemic activity?
Minor issues: -There seem to be altogether 16 patients (6 active and 10 control) in one study on epidural ketamine. The way this information in now presented in the figure 5 gives an exaggerated idea of this minuscule piece of information.
VERSION 1 -AUTHOR RESPONSE Reviewer: 1
Reviewer Name: Peter Goldblatt Institution and Country: UCL Institute of Health Equity, United Kingdom Please state any competing interests or state 'None declared': None Comment 1 This paper presents a thorough review of the available literature on the safety and efficacy of ketamine after total joint arthroplasty using rigorous PRISMA criteria. The main result, that ketamine provides effective pain relief and reduces cumulative morphine consumption without increasing psychotic and gastrointestinal adverse effects is well founded. However, the result of applying the PRISMA criteria is that this based on just nine studies with diverse study designs, covering 239 patients given ketamine in very different treatment regimes compared to 249 controls. Therefore, when the authors attempt to disaggregate the main finding by IA versus IV and by early and late post-operative period, they are often comparing one or two very different studies, each comprising only 20 or 30 patients given ketamine (see Table1). It is unclear whether effect sizes based on one or two studies are controlled for other confounding factors that distinguish the studies, as some of the corrections required could not have been undertaken by the authors of the original studies. For these reasons, the authors should be more cautious in presenting their disaggregated findings, particularly in the abstract. Response: Thank you very much for your kind comments. We agree with you that we should be more cautious in our disaggregated findings. Thus we have modified all relevant statements accordingly in our revised manuscript. We hope that it could make our manuscript more qualified. Thanks again! Comment 2 Specifically, it would be more informative if the authors (i) in the abstract, presented the number of studies on which a disaggregated finding is based Response: We have added the number of studies in disaggregated results accordingly in the revised manuscript. Action: Please see the next one.
Comment 3 (ii) in both the abstract and results, indicated the pooled sample sizes (cases and controls) on which disaggregated results are based Response: We have added the number of studies and the pooled sample sizes in disaggregated results accordingly in the revised manuscript. Action: "A total of ten studies were included. One of them was rated as low quality. Pooled data showed that, compared with placebo, intravenous ketamine was effective for pain relief during 0-8 hour (WMD -1.21, 95% CI -1.45 to -0.98, p < 0.001; 3 studies, 149 participants) but not during 8-24 hour post-operative periods, and effective for reduction of cumulative morphine consumption during both 0-24 hour (WMD -17.76, 95% CI -31.25 to -4.27, p = 0.01; 5 studies, 366 participants) and 0-48 hour (WMD -21.79, 95% CI -25.46 to -18.11, p < 0.001; 4 studies, 252 participants) post-operative periods, without increasing risks of gastrointestinal or psychotic adverse effects. Similar results were also derived from intraarticular (2 studies, 83 participants) and epidural (1 study, 20 participants) administrations of ketamine." (clean version: page 2, line 36-45) Comment 4 (iii) in the results section, when presenting disaggregated results based on only one or two studies, indicate the confounding factors in the study design that might have contributed to the finding and whether or not that was addressed by the original author of the paper. Response: Done accordingly. We added statements in the revised manuscript accordingly. Action: "Only one study,24 conducted on a small-sized sample, reported that the epidural administration of ketamine had significantly lower pain scores compared with the placebo during the late post-operative period (WMD -2.10, 95% CI -3.30 to -0.90, p < 0.001; 1 study, 20 participants). There is a paucity of data regarding acute pain relief efficacy of ketamine in this route during the early postoperative period." (clean version: page 9, line 219-223) "No study was conducted focusing on whether epidural ketamine was effective in reducing cumulative morphine consumption." (clean version: page 9 and 10, line 243-244) "Only one study,24 conducted on a small-sized sample, reported that the incidence of adverse effects in the epidural administration of ketamine group was significantly lower than that in the control group with regard to gastrointestinal adverse effects (RR 0.06, 95% CI 0.00 to 0.90, p = 0.04; 1 study, 20 participants), but not to psychotic adverse effects (RR 0.67, 95% CI 0.27 to 1.66, p = 0.38; 1 study, 20 participants)." (clean version: page 10 and 11, line 270-274) Comment 5 Specific drafting points Page 2, lines 44 to 48 (overall conclusion) The IA results quoted seem to be based on just one paper with 21 patients -requires some qualification. Response: We agree with your comment. Thus we have modified our conclusion in our revised manuscript. Action: "Intravenous administration of ketamine is effective and safe for postoperative pain relief in patients undergoing total knee or hip arthroplasty. Meanwhile, similar beneficial effects were also found in intraarticular and epidural administration of ketamine, but such findings were uncertain due to limited available evidence." (clean version: page 2, line 46-50; page 14, line 370-373) Comment 6 Page 9, line 236 to 239 The words "regards to" are missing from "with the gastrointestinal" and "with the psychotic" Response: Sorry for our negligence! We have modified this sentence and polished the whole manuscript. Action: "The combined data of two studies17,18 showed that there was no significant difference between the intraarticular administration of ketamine group and control group with regard to gastrointestinal adverse effects (RR 1.00, 95% CI 0.53 to 1.89, p = 0.99; 2 studies, 79 participants), with no substantial heterogeneity (I2 = 0%; p = 0.51)." (clean version: page 10, line 260-264) Comment 7 Page 10 line 248 to 250 Since there was only one small study of epidural administration and one slightly larger study of IA, should these be excluded from the main findings of the paper and the results presented in terms of the efficacy and safety of IV administration (based on 202 patients given ketamine)? Response: Many thanks for your advice. We have rewritten relevant statements about the intraarticular and epidural administration of ketamine in the revised manuscript. Action: "Similar results were also derived from intraarticular (2 studies, 83 participants) and epidural (1 study, 20 participants) administrations of ketamine." (clean version: page 2, line 44-45) "Intravenous administration of ketamine is effective and safe for postoperative pain relief in patients undergoing total knee or hip arthroplasty. Meanwhile, similar beneficial effects were also found in intraarticular and epidural administration of ketamine, but such findings were uncertain due to limited available evidence." (clean version: page 2, line 46-50; page 14, line 370-373) "Similar findings were obtained for the intraarticular and epidural administration of ketamine as well. However, due to insufficiency of evidence, findings with regard to these two administration routes need to be confirmed by more quantitative studies." (clean version: page 11, line 280-283) Reviewer: 2 Reviewer Name: Vesa Kontinen Institution and Country: Helsinki University Hospital, Finland Please state any competing interests or state 'None declared': Author of the Brinck et al 2019 Cochrane review on periperative intravenous ketamine for postoperative pain.
Comment 1 This is a systematic review on the effects of perioperative ketamine on postoperative pain after total hip or knee arthroplasty. Intravenous, intraarticular and epidural administration routes were studied. Most of the trials where intravenous ketamine has been studied are included in the resent large Cochrane review on this topic (Brinck et al 2018), and analysed there as a separate subgroup of orthopaedic studies. There also several other systematic reviews on perioperative ketamine for postoperative pain after different types of surgery. Thus, this review does not add substantially to the knowledge on this topic. On a mechanistic view, the site of action and the pharmacological mechanism of intra-articular ketamine is especially problematic after total arthroplasty, when the possible targets within the joint have been removed and replaced with the prosthesis. It would be helpful to discuss what could be the mechanism of action and target site of the intra-articular ketamine after total arthroplasty. Does the joint act merely as a depot for delayed systemic activity? Response: Brinck et al. conducted a large review to investigate the efficacy and safety of intravenous administration of ketamine for post-operative pain relief. It is obvious that the authors have dedicated significant time and effort to completing this great work. However, to further facilitate the clinical decision making, health care providers still need to know how well ketamine in different administration routes works as an analgesic and what the incidence of adverse effects is after total joint arthroplasty. As no previous study focusing on this topic, therefore, the value of the present manuscript should not be diminished. In addition, we appreciate the great advice provided by the reviewer. As a specific administration route after joint surgery, the intraarticular administration of ketamine, just like the cocktail injection therapy, may has its own mechanism. In the revised manuscript, we have added some sentences to discuss the potential mechanism of the intraarticular administration of ketamine. Action: "Intraarticular injection is simple and requires no special expertise or equipment. Ketamine is rarely used intraarticularly, but research findings suggest that this drug may be used as an adjuvant analgesic administered by intraarticular injection after knee arthroscopy. 41, 42 Lawland et al.43 concluded that, because the peripheral administration of NMDA and non-NMDA receptor antagonists directly into the joint was shown to have an antihyperalgesic effect, both NMDA and non-NMDA receptors were activated in the joint. Furthermore, in addition to chondrocytes,44 NMDA receptor was also evidence to be expressed in human synoviocytes.45,46 Thus, it may explain, at least in part, why the intraarticular administration of ketamine is probably effective for postoperative analgesia in patients undergoing total knee or hip arthroplasty." (clean version: page 13, line 346-356) Comment 2 Minor issues: -There seem to be altogether 16 patients (6 active and 10 control) in one study on epidural ketamine. The way this information in now presented in the figure 5 gives an exaggerated idea of this minuscule piece of information. Response: We agree with the reviewer's comment. Thus we have excluded it from the main findings of our manuscript. Action: "Similar results were also derived from intraarticular (2 studies, 83 participants) and epidural (1 study, 20 participants) administrations of ketamine." (clean version: page 2, line 44-45) "Intravenous administration of ketamine is effective and safe for postoperative pain relief in patients undergoing total knee or hip arthroplasty. Meanwhile, similar beneficial effects were also found in intraarticular and epidural administration of ketamine, but such findings were uncertain due to limited available evidence." (clean version: page 2, line 46-50; page 14, line 370-373) "Similar findings were obtained for the intraarticular and epidural administration of ketamine as well. However, due to insufficiency of evidence, findings with regard to these two administration routes need to be confirmed by more quantitative studies." (clean version: page 11, line 280-283)
VERSION 2 -REVIEW

REVIEWER
Peter Goldblatt UCL Institute of Health Equity REVIEW RETURNED
13-Jun-2019
GENERAL COMMENTS
The authors have addressed the major concerns of the reviewers.
However, in trying to present some simple take-home messages from the meta-analysis, I think they have ended up oversimplifying the complexity of the slightly conflicting studies included in the meta-analysis.
In the abstract, discussion and conclusion they say that "similar" beneficial effects were found in intraarticular and epidural administration as for intravenous. However, to briefly summarisefor intraarticular and epidural administration, there was little or no evidence of effect on pain in the early post-operative period and consistent evidence of effect in the late post-operative period. By contrast, for intravenous administration there was a strong effect in the early period and any evidence of an effect in the late period was lost due to heterogeneity of the substantially larger number of studies available for analysis.
In terms of reduced morphine consumption, there was only one study of intraarticular administration and that showed only a very weak effect in one time period, compared to much larger effects in both time periods for intravenous administration.
In view of this complex set of findings, the term "similar" is inappropriate to describe the comparison between the three forms of administration.
It might be better to simply conclude something along the lines of "The limited data available for intraarticular and epidural administration pointed to a significant reduction in pain in the late post-operative period."
Anything beyond this is compromised by small numbers of studies and heterogeneity of results for intravenous administration. The authors have addressed the major concerns of the reviewers. However, in trying to present some simple take-home messages from the meta-analysis, I think they have ended up over-simplifying the complexity of the slightly conflicting studies included in the meta-analysis.
VERSION 2 -AUTHOR RESPONSE
In the abstract, discussion and conclusion they say that "similar" beneficial effects were found in intraarticular and epidural administration as for intravenous. However, to briefly summarise -for intraarticular and epidural administration, there was little or no evidence of effect on pain in the early post-operative period and consistent evidence of effect in the late post-operative period. By contrast, for intravenous administration there was a strong effect in the early period and any evidence of an effect in the late period was lost due to heterogeneity of the substantially larger number of studies available for analysis. In terms of reduced morphine consumption, there was only one study of intraarticular administration and that showed only a very weak effect in one time period, compared to much larger effects in both time periods for intravenous administration. In view of this complex set of findings, the term "similar" is inappropriate to describe the comparison between the three forms of administration. It might be better to simply conclude something along the lines of "The limited data available for intraarticular and epidural administration pointed to a significant reduction in pain in the late post-operative period." Anything beyond this is compromised by small numbers of studies and heterogeneity of results for intravenous administration.
Response:
Many thanks for your kind comments. We have modified all relevant statements accordingly in our revised manuscript.
Action:
1) "The limited data available for intraarticular (WMD -0.49, 95% CI -0.70 to -0.29, p < 0.001; 2 studies, 83 participants) and epidural (WMD -2.10, 95% CI -3.30 to -0.90, p < 0.001; 1 study, 20 participants) ketamine pointed to a significant reduction in pain intensity during 8-24 hour postoperative period." (clean version: line 43-47).
2) "Intravenous administration of ketamine is effective and safe for postoperative pain relief in patients undergoing total knee or hip arthroplasty. Nevertheless, the analgesic efficacy and safety of ketamine in such patients seems to vary by different administration routes and still warrants further studies to explore." (clean version: line 48-51)
3) "In addition, the limited data available for intraarticular and epidural administration of ketamine pointed to a significant reduction in pain intensity during the late post-operative period." (clean version: line 281-284) 4) "Intravenous administration of ketamine is effective and safe for postoperative pain relief in patients undergoing total knee or hip arthroplasty. Nevertheless, the analgesic efficacy and safety of ketamine in such patients seems to vary by different administration routes and still warrants further studies to explore." (clean version: line 372-375)
VERSION 3 -REVIEW
REVIEWER
Peter Goldblatt UCL INstitute of Health Equity United Kingdom
